AR080466A1 - Enriquecimiento selectivo de anticuerpos - Google Patents
Enriquecimiento selectivo de anticuerposInfo
- Publication number
- AR080466A1 AR080466A1 ARP110100705A ARP110100705A AR080466A1 AR 080466 A1 AR080466 A1 AR 080466A1 AR P110100705 A ARP110100705 A AR P110100705A AR P110100705 A ARP110100705 A AR P110100705A AR 080466 A1 AR080466 A1 AR 080466A1
- Authority
- AR
- Argentina
- Prior art keywords
- binding
- selective enrichment
- antibodies
- protein
- target protein
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 102000014914 Carrier Proteins Human genes 0.000 abstract 2
- 108091008324 binding proteins Proteins 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 229940072221 immunoglobulins Drugs 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
- C07K1/32—Extraction; Separation; Purification by precipitation as complexes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
- C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Un procedimiento para el enriquecimiento selectivo de inmunoglobulinas u otras proteínas que contienen un dominio Fc (proteína diana), con las etapas: e. proporcionar una solucion que contiene la proteína diana; f. incorporar una proteína de union de Fc con exactamente dos sitios de union en condiciones que posibilitan una union; g. separar el precipitado de la fase líquida; h. liberar la union de la proteína diana con la proteína de union de Fc.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10155647 | 2010-03-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR080466A1 true AR080466A1 (es) | 2012-04-11 |
Family
ID=42470646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110100705A AR080466A1 (es) | 2010-03-05 | 2011-03-04 | Enriquecimiento selectivo de anticuerpos |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20120071637A1 (es) |
| EP (1) | EP2542567B1 (es) |
| JP (1) | JP5917417B2 (es) |
| KR (1) | KR101855714B1 (es) |
| CN (1) | CN102791728B (es) |
| AR (1) | AR080466A1 (es) |
| AU (1) | AU2011222991B2 (es) |
| CA (1) | CA2791918C (es) |
| SG (1) | SG183920A1 (es) |
| TW (1) | TW201144325A (es) |
| WO (1) | WO2011107518A1 (es) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| CN106084062B (zh) * | 2015-04-28 | 2021-04-02 | 荣昌生物制药(烟台)有限公司 | 桥连的双特异性融合蛋白 |
| US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
| ES2909833T3 (es) | 2016-05-11 | 2022-05-10 | Cytiva Bioprocess R & D Ab | Método de limpieza y/o desinfección de una matriz de separación |
| US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| ES2914278T3 (es) * | 2016-05-11 | 2022-06-08 | Cytiva Bioprocess R & D Ab | Polipéptidos de unión a inmunoglobulina mutados |
| CN109311949B (zh) | 2016-05-11 | 2022-09-16 | 思拓凡生物工艺研发有限公司 | 储存分离基质的方法 |
| EP3455243B1 (en) | 2016-05-11 | 2021-03-24 | Cytiva BioProcess R&D AB | Separation matrix |
| JP7031934B2 (ja) | 2016-05-11 | 2022-03-08 | サイティバ・バイオプロセス・アールアンドディ・アクチボラグ | 分離マトリックス |
| US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| US12448411B2 (en) | 2016-09-30 | 2025-10-21 | Cytiva Bioprocess R&D Ab | Separation method |
| JP7053577B2 (ja) * | 2017-03-31 | 2022-04-12 | 株式会社カネカ | 免疫グロブリン精製用アフィニティー分離マトリックス |
| WO2020018732A1 (en) * | 2018-07-19 | 2020-01-23 | Ab Studio Inc. | Novel systems for screening internalizing antibody and uses thereof |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0560807A1 (en) * | 1990-11-26 | 1993-09-22 | The Public Health Laboratory Service Board | Immunoglobulin-binding proteins and recombinant dna molecules coding therefor |
| JP2584697B2 (ja) * | 1991-08-23 | 1997-02-26 | オリエンタル酵母工業株式会社 | IgG精製用組換え型プロテインA |
| WO1995006125A1 (en) * | 1993-08-23 | 1995-03-02 | Applied Immune Sciences, Inc. | CHIMERIC RECEPTOR CONTAINING ONE IgG BINDING DOMAIN OF BOTH PROTEIN A AND PROTEIN G |
| US6949244B1 (en) | 1995-12-20 | 2005-09-27 | The Board Of Trustees Of The University Of Kentucky | Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| SE9901379D0 (sv) | 1999-04-19 | 1999-04-19 | Pharmacia & Upjohn Ab | Receptor structures |
| US20040077017A1 (en) * | 2001-01-12 | 2004-04-22 | Amelie Karlstrom | Detection methods |
| US7709209B2 (en) * | 2002-03-25 | 2010-05-04 | Ge Healthcare Bio-Sciences Ab | Protein ligands |
| EP1592970A4 (en) * | 2003-02-11 | 2007-09-19 | Univ Washington | REAGENT RESPONSE POLYMER CONJUGATES AND ASSOCIATED METHODS |
| IL157086A0 (en) | 2003-07-24 | 2004-02-08 | Guy Patchornik | Multivalent ligand complexes |
| CA2586803C (en) | 2004-12-14 | 2012-12-11 | Ge Healthcare Bio-Sciences Ab | Purification of immunoglobulins |
| US8728828B2 (en) * | 2004-12-22 | 2014-05-20 | Ge Healthcare Bio-Sciences Ab | Purification of immunoglobulins |
| CN101213211A (zh) * | 2005-06-17 | 2008-07-02 | 惠氏公司 | 纯化含Fc区蛋白的方法 |
| CN102989018A (zh) * | 2005-08-03 | 2013-03-27 | Rq生物科技有限公司 | 用于诊断IgA和IgM介导的肾脏疾病的方法和组合物 |
| JP4481260B2 (ja) * | 2006-03-16 | 2010-06-16 | 株式会社カネカ | 抗体結合性ペプチド |
| EP2066419B1 (en) | 2006-09-29 | 2015-11-11 | GE Healthcare Bio-Sciences AB | Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation |
| WO2008067547A2 (en) * | 2006-11-30 | 2008-06-05 | Research Development Foundation | Improved immunoglobulin libraries |
| US7691608B2 (en) | 2006-12-06 | 2010-04-06 | Repligen Corporation | Nucleic acids encoding recombinant protein A |
| PL2220107T3 (pl) | 2007-11-12 | 2017-05-31 | Chreto Aps | Polipeptydy o podwójnym powinowactwie do oczyszczania |
| US8592555B2 (en) * | 2008-08-11 | 2013-11-26 | Emd Millipore Corporation | Immunoglobulin-binding proteins with improved specificity |
| US20120149875A1 (en) * | 2009-01-12 | 2012-06-14 | Ge Healthcare Bio-Sciences Ab | Affinity chromatography matrix |
-
2011
- 2011-03-02 AU AU2011222991A patent/AU2011222991B2/en active Active
- 2011-03-02 KR KR1020127023113A patent/KR101855714B1/ko active Active
- 2011-03-02 SG SG2012065769A patent/SG183920A1/en unknown
- 2011-03-02 CA CA2791918A patent/CA2791918C/en active Active
- 2011-03-02 EP EP11707643.0A patent/EP2542567B1/de active Active
- 2011-03-02 WO PCT/EP2011/053126 patent/WO2011107518A1/de not_active Ceased
- 2011-03-02 JP JP2012555413A patent/JP5917417B2/ja active Active
- 2011-03-02 CN CN201180012227.2A patent/CN102791728B/zh active Active
- 2011-03-04 AR ARP110100705A patent/AR080466A1/es unknown
- 2011-03-04 TW TW100107413A patent/TW201144325A/zh unknown
- 2011-03-04 US US13/040,361 patent/US20120071637A1/en not_active Abandoned
-
2014
- 2014-01-10 US US14/151,949 patent/US10894806B2/en active Active
-
2020
- 2020-12-16 US US17/123,656 patent/US20210107937A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011107518A1 (de) | 2011-09-09 |
| AU2011222991B2 (en) | 2015-07-16 |
| KR20130004476A (ko) | 2013-01-10 |
| TW201144325A (en) | 2011-12-16 |
| CA2791918A1 (en) | 2011-09-09 |
| US20140128578A1 (en) | 2014-05-08 |
| KR101855714B1 (ko) | 2018-05-10 |
| JP5917417B2 (ja) | 2016-05-11 |
| US10894806B2 (en) | 2021-01-19 |
| JP2013521258A (ja) | 2013-06-10 |
| CN102791728B (zh) | 2015-04-01 |
| SG183920A1 (en) | 2012-10-30 |
| EP2542567A2 (de) | 2013-01-09 |
| AU2011222991A1 (en) | 2012-09-20 |
| EP2542567B1 (de) | 2020-02-12 |
| US20210107937A1 (en) | 2021-04-15 |
| CA2791918C (en) | 2019-11-19 |
| US20120071637A1 (en) | 2012-03-22 |
| CN102791728A (zh) | 2012-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR080466A1 (es) | Enriquecimiento selectivo de anticuerpos | |
| CL2018000461A1 (es) | Anticuerpos biespecíficos con tetravalencia para un receptor de fnt coestimulador. | |
| CY1124108T1 (el) | Μορια συνδεσης που αναστελουν την αναπτυξη καρκινου | |
| CY1123518T1 (el) | Ανθρωπινα αντισωματα enanti-tau | |
| MX2023006482A (es) | Anticuerpos biespecificos especificos para un receptor de tnf coestimulador. | |
| CY1120951T1 (el) | Ανθρωπινα αντισωματα enanti-tau | |
| EA201100300A1 (ru) | Композиции и способы, предназначенные для направленного воздействия антител на белок c5 системы комплемента | |
| EA201690492A1 (ru) | Проникающие в клетку конъюгаты и способы их применения | |
| WO2012142515A3 (en) | Fc fusion proteins comprising novel linkers or arrangements | |
| EA201201016A1 (ru) | Антидоты антикоагулянтов | |
| SG195073A1 (en) | Deimmunized serum-binding domains and their use for extending serum half-life | |
| EA201170030A1 (ru) | Il-6-опосредованная иммунотерапия | |
| EA201391564A1 (ru) | Полипептиды антитела, которые антагонизируют cd40 | |
| CR20110544A (es) | Anticuerpo antagonista específico para el heterodímero de alfa-4-beta-7 | |
| BR112014008382A2 (pt) | anticorpo especificamente ligando a epítope no domínio sema do c-met | |
| BR112014028785A2 (pt) | proteínas de ligação a antígeno de st2 | |
| BR112015017354A2 (pt) | método para detectar pelo menos uma base modificada | |
| WO2013115410A3 (en) | Anti-phospholipase d4 antibody | |
| MX2021001418A (es) | Produccion de proteinas heteromultimericas usando celulas de mamifero. | |
| MX377780B (es) | Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes. | |
| BR112014019773A8 (pt) | Ligantes para anticorpo e proteína de fusão fc para cromatografia de afinidade | |
| CL2014000434A1 (es) | Metodo para determinar la presencia o ausencia de un anticuerpo que se enlaza de manera específica a una proteína e (rns) de virus de diarrea viral bovina (bvdv); equipo de diagnostico que comprende los reactivos. | |
| HK1220456A1 (zh) | 6-乙酰吗啡类似物,和其合成方法和用途 | |
| WO2011133608A3 (en) | Engineering surface epitopes to improve protein crystallization | |
| CY1120686T1 (el) | Αντισωματα ειδικα για το ανθρωπινο πολυπεπτιδιο αμυλοειδους των νησιδιων (ηιαρρ) και χρησεις αυτων |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |